| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | 2.19e-05 | 130 | 178 | 8 | GO:0005200 | |
| MousePheno | abnormal nasopharynx morphology | 2.87e-05 | 7 | 133 | 3 | MP:0002251 | |
| MousePheno | embryonic lethality during organogenesis, complete penetrance | LIAS ACD BCAS3 FRS2 CHD7 HUWE1 ACVRL1 PTCH1 PDIA3 MED24 OTX2 MTHFD1 CD2BP2 TLN1 TAX1BP1 PXN CABIN1 TMEM100 DISP1 | 3.42e-05 | 700 | 133 | 19 | MP:0011098 |
| MousePheno | microcephaly | 3.80e-05 | 97 | 133 | 7 | MP:0000433 | |
| MousePheno | absent distortion product otoacoustic emissions | 4.12e-05 | 41 | 133 | 5 | MP:0004737 | |
| MousePheno | abnormal embryo size | CACNA1S LIAS STRN3 TRIO FRS2 HUWE1 PTCH1 PDIA3 GREB1L MED24 LONP1 OTX2 DST TUBA1A MTHFD1 TLN1 ZFP91 PXN PAK2 CHCHD1 TMEM100 DISP1 | 9.43e-05 | 956 | 133 | 22 | MP:0001697 |
| Domain | Alpha_tubulin | 7.87e-09 | 9 | 173 | 5 | IPR002452 | |
| Domain | Tubulin_C | 1.49e-06 | 22 | 173 | 5 | PF03953 | |
| Domain | Tubulin/FtsZ_2-layer-sand-dom | 1.49e-06 | 22 | 173 | 5 | IPR018316 | |
| Domain | Tubulin_C | 1.49e-06 | 22 | 173 | 5 | SM00865 | |
| Domain | Tub_FtsZ_C | 1.89e-06 | 23 | 173 | 5 | IPR008280 | |
| Domain | Tubulin_C | 1.89e-06 | 23 | 173 | 5 | IPR023123 | |
| Domain | TUBULIN | 1.89e-06 | 23 | 173 | 5 | PS00227 | |
| Domain | Tubulin | 1.89e-06 | 23 | 173 | 5 | IPR000217 | |
| Domain | Tubulin | 1.89e-06 | 23 | 173 | 5 | SM00864 | |
| Domain | Tubulin_CS | 1.89e-06 | 23 | 173 | 5 | IPR017975 | |
| Domain | Tubulin_FtsZ_GTPase | 2.37e-06 | 24 | 173 | 5 | IPR003008 | |
| Domain | Tubulin | 2.37e-06 | 24 | 173 | 5 | PF00091 | |
| Domain | - | 3.07e-05 | 20 | 173 | 4 | 3.30.1330.20 | |
| Domain | - | 3.76e-05 | 21 | 173 | 4 | 1.10.287.600 | |
| Domain | - | 4.57e-05 | 22 | 173 | 4 | 3.40.50.1440 | |
| Domain | Tankyrase-bd_C | 8.53e-05 | 2 | 173 | 2 | IPR032764 | |
| Domain | Tankyrase_bdg_C | 8.53e-05 | 2 | 173 | 2 | SM01319 | |
| Domain | Tankyrase_bdg_C | 8.53e-05 | 2 | 173 | 2 | PF15327 | |
| Domain | IRS | 2.64e-04 | 14 | 173 | 3 | PF02174 | |
| Domain | IRS_PTB | 2.64e-04 | 14 | 173 | 3 | IPR002404 | |
| Domain | - | 6.05e-04 | 42 | 173 | 4 | 3.20.20.70 | |
| Domain | Aldolase_TIM | 7.23e-04 | 44 | 173 | 4 | IPR013785 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RETROGRADE_AXONAL_TRANSPORT | 1.18e-07 | 43 | 130 | 7 | M47669 | |
| Pathway | REACTOME_ASSEMBLY_AND_CELL_SURFACE_PRESENTATION_OF_NMDA_RECEPTORS | 1.39e-07 | 44 | 130 | 7 | M27934 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT | 1.63e-07 | 45 | 130 | 7 | M47670 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_ESPG_TO_MICROTUBULE_RHOA_SIGNALING_PATHWAY | 3.50e-07 | 17 | 130 | 5 | M47768 | |
| Pathway | REACTOME_TRANSPORT_OF_CONNEXONS_TO_THE_PLASMA_MEMBRANE | 3.50e-07 | 17 | 130 | 5 | MM14731 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_DCTN1_TO_RETROGRADE_AXONAL_TRANSPORT | 4.80e-07 | 18 | 130 | 5 | M47753 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_IRON_TO_ANTEROGRADE_AXONAL_TRANSPORT | 6.47e-07 | 19 | 130 | 5 | M47818 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_ZN_TO_ANTEROGRADE_AXONAL_TRANSPORT | 6.47e-07 | 19 | 130 | 5 | M47813 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KINETOCHORE_MICROTUBULE_ATTACHMENT | 8.57e-07 | 20 | 130 | 5 | M47890 | |
| Pathway | BIOCARTA_MTA3_PATHWAY | 8.57e-07 | 20 | 130 | 5 | MM1383 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_DEPOLYMERIZATION_AT_THE_MINUS_ENDS | 8.57e-07 | 20 | 130 | 5 | M47911 | |
| Pathway | REACTOME_TRANSPORT_OF_CONNEXONS_TO_THE_PLASMA_MEMBRANE | 1.12e-06 | 21 | 130 | 5 | M27067 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_RHOA_SIGNALING_PATHWAY | 1.12e-06 | 21 | 130 | 5 | M47767 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PROMOTION_OF_MICROTUBULE_GROWTH | 1.43e-06 | 22 | 130 | 5 | M47903 | |
| Pathway | REACTOME_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY | 1.82e-06 | 23 | 130 | 5 | M19135 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_DEPOLYMERIZATION | 1.82e-06 | 23 | 130 | 5 | M47910 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KINETOCHORE_FIBER_ORGANIZATION | 1.82e-06 | 23 | 130 | 5 | M47900 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANTEROGRADE_AXONAL_TRANSPORT | 2.28e-06 | 24 | 130 | 5 | M47671 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_ANTEROGRADE_AXONAL_TRANSPORT | 2.28e-06 | 24 | 130 | 5 | M47700 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SALMONELLA_SIFA_TO_MICROTUBULE_PLUS_END_DIRECTED_TRANSPORT | 2.83e-06 | 25 | 130 | 5 | M47775 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SNCA_TO_ANTEROGRADE_AXONAL_TRANSPORT | 2.83e-06 | 25 | 130 | 5 | M47710 | |
| Pathway | REACTOME_FORMATION_OF_TUBULIN_FOLDING_INTERMEDIATES_BY_CCT_TRIC | 3.48e-06 | 26 | 130 | 5 | M9648 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_ANTEROGRADE_AXONAL_TRANSPORT | 3.48e-06 | 26 | 130 | 5 | M47672 | |
| Pathway | REACTOME_CARBOXYTERMINAL_POST_TRANSLATIONAL_MODIFICATIONS_OF_TUBULIN | 4.24e-06 | 27 | 130 | 5 | MM15549 | |
| Pathway | REACTOME_SEALING_OF_THE_NUCLEAR_ENVELOPE_NE_BY_ESCRT_III | 4.24e-06 | 27 | 130 | 5 | MM15674 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_NUCLEATION | 5.12e-06 | 28 | 130 | 5 | M47898 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS | 6.14e-06 | 29 | 130 | 5 | MM15219 | |
| Pathway | REACTOME_ACTIVATION_OF_AMPK_DOWNSTREAM_OF_NMDARS | 6.14e-06 | 29 | 130 | 5 | M27948 | |
| Pathway | REACTOME_SEALING_OF_THE_NUCLEAR_ENVELOPE_NE_BY_ESCRT_III | 1.02e-05 | 32 | 130 | 5 | M29848 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS | 1.02e-05 | 32 | 130 | 5 | M27491 | |
| Pathway | REACTOME_GAP_JUNCTION_ASSEMBLY | 1.02e-05 | 32 | 130 | 5 | MM14730 | |
| Pathway | REACTOME_COOPERATION_OF_PREFOLDIN_AND_TRIC_CCT_IN_ACTIN_AND_TUBULIN_FOLDING | 1.19e-05 | 33 | 130 | 5 | M27297 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BRANCHING_MICROTUBULE_NUCLEATION | 1.19e-05 | 33 | 130 | 5 | M47901 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ARL8_REGULATED_MICROTUBULE_PLUS_END_DIRECTED_TRANSPORT | 1.61e-05 | 35 | 130 | 5 | M47774 | |
| Pathway | REACTOME_AGGREPHAGY | 1.85e-05 | 36 | 130 | 5 | MM15669 | |
| Pathway | REACTOME_RECYCLING_PATHWAY_OF_L1 | 2.12e-05 | 37 | 130 | 5 | MM15102 | |
| Pathway | REACTOME_GAP_JUNCTION_ASSEMBLY | 2.43e-05 | 38 | 130 | 5 | M14981 | |
| Pathway | REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS | 2.54e-05 | 94 | 130 | 7 | M2843 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | DSCAM TRIO TUBA1C FRS2 TUBA8 TUBA4A TUBA1B TUBA1A TLN1 PAK2 EPHB1 | 2.95e-05 | 261 | 130 | 11 | MM15676 |
| Pathway | REACTOME_PKR_MEDIATED_SIGNALING | 3.16e-05 | 66 | 130 | 6 | MM17074 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RAB7_REGULATED_MICROTUBULE_MINUS_END_DIRECTED_TRANSPORT | 4.49e-05 | 43 | 130 | 5 | M47773 | |
| Pathway | WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY | 4.80e-05 | 71 | 130 | 6 | M39690 | |
| Pathway | REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION | 5.02e-05 | 44 | 130 | 5 | MM14606 | |
| Pathway | REACTOME_AGGREPHAGY | 5.02e-05 | 44 | 130 | 5 | M29830 | |
| Pathway | REACTOME_TRANSLOCATION_OF_SLC2A4_GLUT4_TO_THE_PLASMA_MEMBRANE | 5.20e-05 | 72 | 130 | 6 | M26954 | |
| Pathway | REACTOME_CARBOXYTERMINAL_POST_TRANSLATIONAL_MODIFICATIONS_OF_TUBULIN | 6.25e-05 | 46 | 130 | 5 | M27828 | |
| Pathway | REACTOME_PKR_MEDIATED_SIGNALING | 7.06e-05 | 76 | 130 | 6 | M48037 | |
| Pathway | REACTOME_COPI_INDEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 7.69e-05 | 48 | 130 | 5 | MM15353 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | CACNA1S ZSWIM8 DSCAM TRIO TUBA1C FRS2 ADGRV1 TUBA8 TUBA4A TUBA1B TUBA1A TLN1 SCN2A PAK2 DLG4 EPHB1 | 7.77e-05 | 575 | 130 | 16 | M29853 |
| Pathway | REACTOME_RECYCLING_PATHWAY_OF_L1 | 8.50e-05 | 49 | 130 | 5 | M891 | |
| Pathway | REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION | 1.03e-04 | 51 | 130 | 5 | M26972 | |
| Pathway | REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND | 1.13e-04 | 52 | 130 | 5 | MM14949 | |
| Pathway | REACTOME_COPI_INDEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 1.24e-04 | 53 | 130 | 5 | M27651 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 1.27e-04 | 121 | 130 | 7 | M872 | |
| Pathway | WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION | 1.48e-04 | 55 | 130 | 5 | M39613 | |
| Pathway | KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION | 1.62e-04 | 56 | 130 | 5 | M2333 | |
| Pathway | REACTOME_KINESINS | 1.76e-04 | 57 | 130 | 5 | MM15714 | |
| Pathway | REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND | 1.76e-04 | 57 | 130 | 5 | M27251 | |
| Pathway | REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES | 2.30e-04 | 94 | 130 | 6 | MM14515 | |
| Pathway | REACTOME_KINESINS | 2.43e-04 | 61 | 130 | 5 | M977 | |
| Pathway | REACTOME_INTERFERON_SIGNALING | 2.87e-04 | 138 | 130 | 7 | MM15635 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_FORMINS | 3.14e-04 | 140 | 130 | 7 | M27550 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_FORMINS | 3.28e-04 | 141 | 130 | 7 | MM15266 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_NE_REASSEMBLY | 4.04e-04 | 68 | 130 | 5 | MM14921 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 4.04e-04 | 68 | 130 | 5 | MM14968 | |
| Pathway | REACTOME_THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT | 5.61e-04 | 73 | 130 | 5 | MM15491 | |
| Pathway | REACTOME_SELECTIVE_AUTOPHAGY | 5.61e-04 | 73 | 130 | 5 | MM15672 | |
| Pathway | REACTOME_ER_TO_GOLGI_ANTEROGRADE_TRANSPORT | 6.02e-04 | 156 | 130 | 7 | M27097 | |
| Pathway | REACTOME_RHO_GTPASE_EFFECTORS | 6.26e-04 | 257 | 130 | 9 | MM14755 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_NE_REASSEMBLY | 6.76e-04 | 76 | 130 | 5 | M27215 | |
| Pathway | REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION | 7.10e-04 | 116 | 130 | 6 | MM14855 | |
| Pathway | REACTOME_THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT | 8.06e-04 | 79 | 130 | 5 | M27743 | |
| Pathway | REACTOME_ER_TO_GOLGI_ANTEROGRADE_TRANSPORT | 9.32e-04 | 168 | 130 | 7 | MM14785 | |
| Pathway | REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION | 1.09e-03 | 126 | 130 | 6 | M705 | |
| Pathway | REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION | 1.14e-03 | 127 | 130 | 6 | M27181 | |
| Pathway | REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION | 1.24e-03 | 129 | 130 | 6 | MM14894 | |
| Pathway | REACTOME_INTRAFLAGELLAR_TRANSPORT | 1.33e-03 | 52 | 130 | 4 | MM15211 | |
| Pathway | WP_KALLMANN_SYNDROME | 1.35e-03 | 24 | 130 | 3 | M42530 | |
| Pathway | REACTOME_SELECTIVE_AUTOPHAGY | 1.45e-03 | 90 | 130 | 5 | M29841 | |
| Pathway | KEGG_GAP_JUNCTION | 1.45e-03 | 90 | 130 | 5 | M4013 | |
| Pathway | REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES | 1.45e-03 | 90 | 130 | 5 | MM14979 | |
| Pathway | REACTOME_INTRAFLAGELLAR_TRANSPORT | 1.53e-03 | 54 | 130 | 4 | M27482 | |
| Pathway | REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION | 1.57e-03 | 293 | 130 | 9 | MM15120 | |
| Pathway | REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION | 1.73e-03 | 187 | 130 | 7 | M961 | |
| Pathway | REACTOME_HCMV_EARLY_EVENTS | 1.74e-03 | 138 | 130 | 6 | M29805 | |
| Pathway | REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES | 1.84e-03 | 95 | 130 | 5 | M6729 | |
| Pathway | REACTOME_COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 2.11e-03 | 98 | 130 | 5 | MM15352 | |
| Pathway | REACTOME_PROTEIN_FOLDING | 2.11e-03 | 98 | 130 | 5 | M776 | |
| Pathway | REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION | 2.16e-03 | 307 | 130 | 9 | M894 | |
| Pathway | REACTOME_COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 2.31e-03 | 100 | 130 | 5 | M27650 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | DSCAM TRIO TUBA1C FRS2 TUBA8 TUBA4A TUBA1B TUBA1A TLN1 PAK2 DLG4 EPHB1 | 2.33e-03 | 502 | 130 | 12 | MM14537 |
| Pathway | REACTOME_COPI_MEDIATED_ANTEROGRADE_TRANSPORT | 2.52e-03 | 102 | 130 | 5 | M27648 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | RAP1GDS1 TRIO TUBA1C FRS3 FRS2 TUBA8 FAM13B TUBA4A TUBA1B PPP2R1B DST TUBA1A DIAPH1 PAK2 DLG4 | 2.60e-03 | 720 | 130 | 15 | M41838 |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | TRIO TUBA1C FRS3 FRS2 TUBA8 FAM13B TUBA4A TUBA1B PPP2R1B DST TUBA1A DIAPH1 PAK2 DLG4 | 2.64e-03 | 649 | 130 | 14 | MM15690 |
| Pathway | REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION | 2.68e-03 | 202 | 130 | 7 | MM15650 | |
| Pathway | REACTOME_MAPK_FAMILY_SIGNALING_CASCADES | 2.73e-03 | 318 | 130 | 9 | MM15278 | |
| Pathway | REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES | 2.74e-03 | 151 | 130 | 6 | M550 | |
| Pathway | REACTOME_HEDGEHOG_OFF_STATE | 2.86e-03 | 105 | 130 | 5 | MM15206 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | 2.91e-03 | 205 | 130 | 7 | M752 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SHIGELLA_IPAB_C_D_TO_ITGA_B_TALIN_VINCULIN_SIGNALING_PATHWAY | 2.91e-03 | 9 | 130 | 2 | M47725 | |
| Pubmed | 1.52e-12 | 9 | 181 | 6 | 21167302 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | TRIO BCAS3 LAMB3 TMCO6 GRID1 SLC10A3 ATG2A HUWE1 PTCH1 SRCAP ZNF236 SLC7A1 FASN GET4 DST CD2BP2 TLN1 NFX1 PXN PCYT2 TNKS1BP1 LRRC14 CABIN1 CHPF TRAPPC9 ABCC10 | 1.46e-10 | 1105 | 181 | 26 | 35748872 |
| Pubmed | Histone deacetylase 6 regulates human immunodeficiency virus type 1 infection. | 2.00e-10 | 8 | 181 | 5 | 16148047 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | DDX47 TUBA1C CHD7 HUWE1 TUBA4A TUBA1B PPP2R1B FASN TRAP1 AP1B1 TLN1 DIAPH1 MED12L UMPS TNKS1BP1 CLP1 HSPA6 APBB1IP | 1.86e-09 | 582 | 181 | 18 | 20467437 |
| Pubmed | The glutamine-rich region of the HIV-1 Tat protein is involved in T-cell apoptosis. | 2.78e-09 | 12 | 181 | 5 | 15331610 | |
| Pubmed | HIV-1 rev depolymerizes microtubules to form stable bilayered rings. | 4.49e-09 | 13 | 181 | 5 | 10908577 | |
| Pubmed | TUBA8 TUBA1B TRAP1 DST DNAJC10 TUBA1A MTHFD1 IRAG2 CROCC DNAH8 HSPA6 | 4.59e-09 | 187 | 181 | 11 | 26460568 | |
| Pubmed | 6.96e-09 | 14 | 181 | 5 | 12486001 | ||
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | TPP2 CACNA1S STRN3 RAP1GDS1 NRDC TUBA1C HUWE1 PDIA3 TUBA4A PPP2R1B FASN TRAP1 GET4 MYG1 AP1B1 TUBA1A MTHFD1 TLN1 CLNS1A DIAPH1 PXN PAK2 PCYT2 TNKS1BP1 CROCC HSPA6 PPP6R3 | 1.04e-08 | 1455 | 181 | 27 | 22863883 |
| Pubmed | 1.06e-08 | 6 | 181 | 4 | 3785200 | ||
| Pubmed | The N-terminal domain of c-Myc associates with alpha-tubulin and microtubules in vivo and in vitro. | 1.06e-08 | 6 | 181 | 4 | 7651436 | |
| Pubmed | 1.06e-08 | 6 | 181 | 4 | 16327313 | ||
| Pubmed | 2.45e-08 | 7 | 181 | 4 | 36681692 | ||
| Pubmed | 2.45e-08 | 7 | 181 | 4 | 11146551 | ||
| Pubmed | TPP2 STRN3 RAP1GDS1 NRDC TRIO WDR7 BCAS3 CAMK2B TUBA1C BRSK2 PDIA3 TUBA4A LONP1 FASN DST AP1B1 TUBA1A SLC24A2 MTHFD1 TLN1 SCN2A DLG4 TNKS1BP1 BRSK1 CROCC TRAPPC9 | 3.07e-08 | 1431 | 181 | 26 | 37142655 | |
| Pubmed | 3.96e-08 | 19 | 181 | 5 | 15698476 | ||
| Pubmed | 3.96e-08 | 19 | 181 | 5 | 15691386 | ||
| Pubmed | 7.75e-08 | 104 | 181 | 8 | 36055981 | ||
| Pubmed | Interaction between metabotropic glutamate receptor 7 and alpha tubulin. | 8.76e-08 | 9 | 181 | 4 | 11953448 | |
| Pubmed | 8.85e-08 | 22 | 181 | 5 | 28117675 | ||
| Pubmed | 8.85e-08 | 22 | 181 | 5 | 15103018 | ||
| Pubmed | TPP2 RAP1GDS1 PCBP3 TUBA1C HUWE1 PDIA3 TUBA4A TUBA1B LONP1 FASN TRAP1 GET4 AP1B1 TUBA1A MTHFD1 TLN1 UMPS HSPA6 PPP6R3 | 1.90e-07 | 878 | 181 | 19 | 37223481 | |
| Pubmed | STRN3 TUBA1C HMGXB4 RALGAPB PHRF1 CHD7 PNKD GREB1L KIAA1671 MED24 TUBA1B DST MTHFD1 CGREF1 TLN1 ZFP91 NFX1 RBM15B SLC35F6 PXN CBX1 CROCC CLP1 HSPA6 PPP6R3 | 2.84e-07 | 1497 | 181 | 25 | 31527615 | |
| Pubmed | 4.89e-07 | 13 | 181 | 4 | 14697242 | ||
| Pubmed | Interlaboratory reproducibility of large-scale human protein-complex analysis by standardized AP-MS. | ZSWIM8 STRN3 AHCYL2 PNKD EPM2AIP1 PHKA2 PPP2R1B LONP1 FASN TRAP1 DST PAK2 PPP6R3 | 4.91e-07 | 432 | 181 | 13 | 23455922 |
| Pubmed | 5.52e-07 | 4 | 181 | 3 | 18400243 | ||
| Pubmed | 6.43e-07 | 94 | 181 | 7 | 36584595 | ||
| Pubmed | TPP2 STRN3 DSCAM TRIO WDR7 CAMK2B ADGRB3 CHD7 HUWE1 EPM2AIP1 DST AP1B1 N4BP2 TAX1BP1 DIAPH1 PAK2 DLG4 BRSK1 CABIN1 | 7.63e-07 | 963 | 181 | 19 | 28671696 | |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | DDX47 LAMB4 STRN3 NRDC BARD1 AHCYL2 ATG2A HUWE1 FEM1C PPP2R1B LONP1 GET4 TUBA1A CD2BP2 CLNS1A CBX1 UMPS LRRC14 PPP6R3 | 1.43e-06 | 1005 | 181 | 19 | 19615732 |
| Pubmed | 1.47e-06 | 206 | 181 | 9 | 22174317 | ||
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | TUBA1C HMGXB4 HUWE1 SRCAP TUBA4A TUBA1B FASN MYG1 MTHFD1 TLN1 UMPS | 1.51e-06 | 332 | 181 | 11 | 32786267 |
| Pubmed | 1.60e-06 | 17 | 181 | 4 | 17360745 | ||
| Pubmed | 2.74e-06 | 6 | 181 | 3 | 18613978 | ||
| Pubmed | 2.74e-06 | 6 | 181 | 3 | 12090300 | ||
| Pubmed | 2.74e-06 | 6 | 181 | 3 | 10840040 | ||
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | A2M TMEM186 NRDC HUWE1 PDIA3 CDC14A CNNM4 PTPN4 PPP2R1B FASN GET4 DNAJC10 AP1B1 CLNS1A PXN UMPS DLG4 PPP6R3 | 3.77e-06 | 974 | 181 | 18 | 28675297 |
| Pubmed | Expanding the Interactome of TES by Exploiting TES Modules with Different Subcellular Localizations. | TUBA1C HUWE1 TUBA4A TUBA1B TRAP1 TLN1 DIAPH1 TNKS1BP1 PPP6R3 | 4.32e-06 | 235 | 181 | 9 | 28378594 |
| Pubmed | Quantitative interactome proteomics identifies a proteostasis network for GABAA receptors. | 4.38e-06 | 125 | 181 | 7 | 36030824 | |
| Pubmed | Synaptic, transcriptional and chromatin genes disrupted in autism. | 4.78e-06 | 7 | 181 | 3 | 25363760 | |
| Pubmed | Systematic Analysis of the Functions of Lysine Acetylation in the Regulation of Tat Activity. | 4.82e-06 | 22 | 181 | 4 | 23826228 | |
| Pubmed | MET Inhibitors Promote Liver Tumor Evasion of the Immune Response by Stabilizing PDL1. | 5.45e-06 | 182 | 181 | 8 | 30711629 | |
| Pubmed | ZSWIM8 RAP1GDS1 PCBP3 PHRF1 BRSK2 ZMAT4 TUBA4A MED24 TUBA1B OTX2 GET4 DST TAX1BP1 CBX1 DLG4 PRMT7 CROCC KRTCAP2 | 5.87e-06 | 1006 | 181 | 18 | 15226823 | |
| Pubmed | 6.33e-06 | 50 | 181 | 5 | 23703321 | ||
| Pubmed | DDX47 TPP2 TUBA1C HUWE1 PDIA3 KIAA1671 CNNM4 PPP2R1B LONP1 FASN NOP9 TRAP1 DST DNAJC10 TUBA1A TLN1 UMPS TNKS1BP1 CABIN1 HSPA6 TRAPPC9 PPP6R3 | 6.52e-06 | 1440 | 181 | 22 | 30833792 | |
| Pubmed | LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells. | ZSWIM8 STRN3 TUBA1C HUWE1 TUBA4A TUBA1B PHKA2 PPP2R1B LONP1 TRAP1 TUBA1A N4BP2 CHCHD1 PPP6R3 | 7.23e-06 | 639 | 181 | 14 | 23443559 |
| Pubmed | PCBP3 TUBA1C TMCO6 CHD7 AHCYL2 TUBA8 TUBA4A TUBA1B FASN TRAP1 GET4 DNAJC10 AP1B1 TUBA1A MTHFD1 CD2BP2 CLNS1A CHCHD1 HSPA6 | 1.02e-05 | 1153 | 181 | 19 | 29845934 | |
| Pubmed | 1.14e-05 | 9 | 181 | 3 | 19103752 | ||
| Pubmed | CHD7 HUWE1 GREB1L KIAA1671 FASN DST N4BP2 PXN TNKS1BP1 CLP1 HSPA6 | 1.34e-05 | 418 | 181 | 11 | 34709266 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | BDP1 ZSWIM8 CAMK2B CHD7 HUWE1 SRCAP KIAA1671 TUBA1A N4BP2 CD2BP2 DIAPH1 TNKS1BP1 PPP6R3 | 1.41e-05 | 588 | 181 | 13 | 38580884 |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | DDX47 TPP2 NRDC TUBA1C AHCYL2 HUWE1 PDIA3 TUBA4A TUBA1B LONP1 FASN DNAJC10 AP1B1 TUBA1A MTHFD1 CD2BP2 TLN1 DIAPH1 TNKS1BP1 HSPA6 PPP6R3 | 1.65e-05 | 1415 | 181 | 21 | 28515276 |
| Pubmed | 14-3-3 cooperates with LKB1 to regulate the activity and localization of QSK and SIK. | 1.75e-05 | 30 | 181 | 4 | 16306228 | |
| Pubmed | Dysferlin interacts with tubulin and microtubules in mouse skeletal muscle. | 2.22e-05 | 11 | 181 | 3 | 20405035 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | TUBA1C HUWE1 SRCAP PDIA3 FASN TRAP1 GET4 MYG1 DST AP1B1 MTHFD1 TLN1 DIAPH1 BRSK1 DISP1 | 2.35e-05 | 807 | 181 | 15 | 30575818 |
| Pubmed | 2.54e-05 | 225 | 181 | 8 | 12168954 | ||
| Pubmed | EphB1-mediated cell migration requires the phosphorylation of paxillin at Tyr-31/Tyr-118. | 2.69e-05 | 2 | 181 | 2 | 15107421 | |
| Pubmed | Bpag1 localization to actin filaments and to the nucleus is regulated by its N-terminus. | 2.69e-05 | 2 | 181 | 2 | 14576348 | |
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 27150043 | ||
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 15094036 | ||
| Pubmed | Broadly expressed SNT-like proteins link FGF receptor stimulation to activators of Ras. | 2.69e-05 | 2 | 181 | 2 | 8761293 | |
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 25328666 | ||
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 12054644 | ||
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 12586769 | ||
| Pubmed | Isozyme-Specific Role of SAD-A in Neuronal Migration During Development of Cerebral Cortex. | 2.69e-05 | 2 | 181 | 2 | 30307479 | |
| Pubmed | Structural features and restricted expression of a human alpha-tubulin gene. | 2.69e-05 | 2 | 181 | 2 | 3839072 | |
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 25151963 | ||
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 17086210 | ||
| Pubmed | Structural and mechanistic insights into the recruitment of talin by RIAM in integrin signaling. | 2.69e-05 | 2 | 181 | 2 | 25465129 | |
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 16630837 | ||
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 29155277 | ||
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 22296162 | ||
| Pubmed | Genomic organization and comparative sequence analysis of the mouse and human FRS2, FRS3 genes. | 2.69e-05 | 2 | 181 | 2 | 12688531 | |
| Pubmed | Investigating the regulation of brain-specific kinases 1 and 2 by phosphorylation. | 2.69e-05 | 2 | 181 | 2 | 18339622 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | DDX47 CAMK2B TUBA1C HUWE1 TUBA4A TUBA1B PPP2R1B FASN TRAP1 GET4 DNAJC10 TUBA1A MTHFD1 CD2BP2 UMPS LRRC14 CLP1 HSPA6 PPP6R3 | 3.35e-05 | 1257 | 181 | 19 | 37317656 |
| Pubmed | 3.36e-05 | 171 | 181 | 7 | 36629882 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | CCDC170 LIAS LAMB4 DNAH2 FRS2 LAMB3 HUWE1 KIAA1671 LOXHD1 DST TUBA1A MTHFD1 TLN1 CLNS1A | 3.45e-05 | 736 | 181 | 14 | 29676528 |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | A2M PCBP3 LAMB3 HUWE1 TUBA8 PDIA3 PPP2R1B FASN AP1B1 MTHFD1 TAX1BP1 TNKS1BP1 PPP6R3 | 3.79e-05 | 647 | 181 | 13 | 26618866 |
| Pubmed | 3.82e-05 | 13 | 181 | 3 | 25775517 | ||
| Pubmed | STRN3 TRIO HMGXB4 PDIA3 TRAP1 DST ZFP91 PXN HAL PRMT7 PPP6R3 | 4.07e-05 | 472 | 181 | 11 | 38943005 | |
| Pubmed | TPP2 ZSWIM8 TUBA1C PHRF1 CHD7 HUWE1 LONP1 FASN DST AP1B1 TLN1 TNKS1BP1 PPP6R3 | 4.16e-05 | 653 | 181 | 13 | 22586326 | |
| Pubmed | 5.22e-05 | 322 | 181 | 9 | 26514267 | ||
| Pubmed | TPP2 RAP1GDS1 WDR7 CAMK2B AHCYL2 PDIA3 TUBA1B FASN AP1B1 DLG4 | 5.45e-05 | 403 | 181 | 10 | 30562941 | |
| Pubmed | TUBA1C LAMB3 PDIA3 TUBA4A TUBA1B PPP2R1B FASN TUBA1A MTHFD1 TLN1 DIAPH1 | 5.49e-05 | 488 | 181 | 11 | 31324722 | |
| Pubmed | 5.87e-05 | 327 | 181 | 9 | 34428256 | ||
| Pubmed | 6.02e-05 | 15 | 181 | 3 | 28112518 | ||
| Pubmed | 6.60e-05 | 332 | 181 | 9 | 37433992 | ||
| Pubmed | Channel-interacting PDZ protein, 'CIPP', interacts with proteins involved in cytoskeletal dynamics. | 7.39e-05 | 16 | 181 | 3 | 19138174 | |
| Pubmed | ZSWIM8 NRDC HUWE1 PDIA3 TUBA1B PPP2R1B LONP1 FASN TRAP1 HMCN2 DNAJC10 AP1B1 TUBA1A MTHFD1 CLNS1A ZFP91 CBX1 HSPA6 PPP6R3 | 7.45e-05 | 1335 | 181 | 19 | 29229926 | |
| Pubmed | 8.00e-05 | 84 | 181 | 5 | 31616248 | ||
| Pubmed | Ski regulates Hippo and TAZ signaling to suppress breast cancer progression. | 8.00e-05 | 84 | 181 | 5 | 25670202 | |
| Pubmed | 8.05e-05 | 3 | 181 | 2 | 23389036 | ||
| Pubmed | Identification of alpha-tubulin as an hsp105alpha-binding protein by the yeast two-hybrid system. | 8.05e-05 | 3 | 181 | 2 | 12749852 | |
| Pubmed | 8.05e-05 | 3 | 181 | 2 | 31767681 | ||
| Pubmed | 8.05e-05 | 3 | 181 | 2 | 12087096 | ||
| Pubmed | 8.05e-05 | 3 | 181 | 2 | 16081825 | ||
| Pubmed | FAK promotes recruitment of talin to nascent adhesions to control cell motility. | 8.05e-05 | 3 | 181 | 2 | 22270917 | |
| Pubmed | 8.05e-05 | 3 | 181 | 2 | 26337492 | ||
| Pubmed | 8.05e-05 | 3 | 181 | 2 | 22669945 | ||
| Pubmed | 8.05e-05 | 3 | 181 | 2 | 19187780 | ||
| Pubmed | 8.05e-05 | 3 | 181 | 2 | 9885248 | ||
| Pubmed | 8.05e-05 | 3 | 181 | 2 | 11279031 | ||
| Interaction | GRM7 interactions | 4.25e-07 | 19 | 170 | 5 | int:GRM7 | |
| Interaction | KCTD9 interactions | TUBA1C PNKD EPM2AIP1 TUBA1B FASN TRAP1 TUBA1A CARD9 MTHFD1 TLN1 ZNF76 HSPA6 | 4.86e-07 | 225 | 170 | 12 | int:KCTD9 |
| Interaction | TCP11L2 interactions | 7.35e-07 | 21 | 170 | 5 | int:TCP11L2 | |
| Interaction | GAN interactions | TUBA8 TUBA1B TRAP1 DST DNAJC10 TUBA1A MTHFD1 IRAG2 CROCC DNAH8 HSPA6 | 1.05e-05 | 253 | 170 | 11 | int:GAN |
| Interaction | CDC5L interactions | DDX47 TRIO TUBA1C HUWE1 CDC14A TUBA4A TUBA1B FASN TRAP1 OTX2 DST AP1B1 CD2BP2 TLN1 DIAPH1 MED12L UMPS TNKS1BP1 HSPA6 PPP6R3 | 3.67e-05 | 855 | 170 | 20 | int:CDC5L |
| Interaction | TOP3B interactions | TRIO BCAS3 LAMB3 TMCO6 GRID1 SLC10A3 ATG2A HUWE1 PTCH1 SRCAP ZNF236 CDC14A SLC7A1 LONP1 FASN GET4 DST CD2BP2 TLN1 NFX1 PXN PCYT2 TNKS1BP1 LRRC14 CABIN1 CHPF TRAPPC9 ABCC10 | 4.03e-05 | 1470 | 170 | 28 | int:TOP3B |
| Interaction | KCTD13 interactions | TPP2 LAMB4 STRN3 RAP1GDS1 NRDC TRIO WDR7 BCAS3 CAMK2B TUBA1C BRSK2 AHCYL2 PDIA3 LONP1 FASN DST AP1B1 TUBA1A SLC24A2 MTHFD1 TLN1 SCN2A DLG4 TNKS1BP1 BRSK1 CROCC TRAPPC9 | 4.24e-05 | 1394 | 170 | 27 | int:KCTD13 |
| Interaction | GABRA1 interactions | 4.55e-05 | 152 | 170 | 8 | int:GABRA1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q35 | 1.67e-04 | 129 | 181 | 5 | chr2q35 | |
| Cytoband | 2q35 | 2.79e-04 | 79 | 181 | 4 | 2q35 | |
| Cytoband | 12q13.12 | 4.59e-04 | 38 | 181 | 3 | 12q13.12 | |
| Cytoband | 10q22.2 | 5.75e-04 | 41 | 181 | 3 | 10q22.2 | |
| GeneFamily | Tubulins | 5.40e-07 | 26 | 114 | 5 | 778 | |
| ToppCell | (00)_Basal-(4)_1wkpi|(00)_Basal / shred by cell type and Timepoint | 9.36e-07 | 185 | 181 | 8 | bf82ba905e5eee1c39a2731702071d3de10a78b8 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class | 1.68e-06 | 200 | 181 | 8 | 2281debd86e5d92e8fe0397aec9ef670800f7471 | |
| ToppCell | LPS-antiTNF-Endothelial-Mes-Like-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.37e-06 | 166 | 181 | 7 | 3b750d4023a0a09d86113aae5a97d84391f7b482 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.59e-06 | 167 | 181 | 7 | 3edb0570e583bb527165bcd8a4c25a042054043b | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.59e-06 | 175 | 181 | 7 | 96219e58dcb327fd27190be78193e7a0d611e62b | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.59e-06 | 175 | 181 | 7 | cb974fbebe8cb58c7d3f7defabb4e056f2fee5fa | |
| ToppCell | Adult-Immune-dendritic_cell-D175|Adult / Lineage, Cell type, age group and donor | 7.88e-06 | 176 | 181 | 7 | 1f0f1f953e6d61119f342de0d980aa1287511dba | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-05 | 184 | 181 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-05 | 184 | 181 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-05 | 184 | 181 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.13e-05 | 186 | 181 | 7 | b45cce768e4bf91da194fd9660cab7520dfb15ac | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.21e-05 | 188 | 181 | 7 | c4c3b21ab723b0e9beff9ec84f8d68485f771528 | |
| ToppCell | droplet-Marrow-BM-1m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-05 | 189 | 181 | 7 | b81540e097e95158851e07bfd78640ed6e64c2cf | |
| ToppCell | droplet-Marrow-BM-1m-Myeloid-Cd4_positive_Macrophages|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-05 | 189 | 181 | 7 | 0fda1a3f1e87fadf5309c8267beaa4501983b1dd | |
| ToppCell | facs-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-05 | 195 | 181 | 7 | bd8e24dd598990204998d1dd853ba7a53dc0107e | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Dendritic-conventional_dendritic_cell-DC_c1-CLEC9A|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.61e-05 | 131 | 181 | 6 | 1823cab28fab40486247ca92104267b1e370bdc1 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Neuronal-Interneuron|2m / Sample Type, Dataset, Time_group, and Cell type. | 1.81e-05 | 200 | 181 | 7 | 08bee924a2654e05df3b39e8a51f93c8b3472175 | |
| Drug | Epothilone D | 2.09e-08 | 12 | 178 | 5 | DB01873 | |
| Drug | Epothilone B | 2.09e-08 | 12 | 178 | 5 | DB03010 | |
| Drug | 2-MERCAPTO-N-[1,2,3,10-TETRAMETHOXY-9-OXO-5,6,7,9-TETRAHYDRO-BENZO[A]HEPTALEN-7-YL]ACETAMIDE | 1.87e-06 | 4 | 178 | 3 | DB07574 | |
| Drug | NSC91998 | 3.39e-06 | 81 | 178 | 7 | CID000005668 | |
| Drug | indole alkaloid | TUBA1C ABCC5 ACVRL1 TUBA8 TUBA4A TRAP1 DNAJC10 TUBA1A PCYT2 HAL ABCC10 | 3.69e-06 | 244 | 178 | 11 | CID000005978 |
| Drug | Minocycline hydrochloride [13614-98-7]; Down 200; 8uM; MCF7; HT_HG-U133A | RETREG2 TRIO CASP2 AHCYL2 SRCAP SLC7A1 CGREF1 TAX1BP1 CABIN1 PRODH | 3.96e-06 | 199 | 178 | 10 | 7436_DN |
| Drug | albendazole | 9.83e-06 | 37 | 178 | 5 | CID000002082 | |
| Drug | PIPES | 1.08e-05 | 64 | 178 | 6 | CID000079723 | |
| Drug | gnoscopine | 1.12e-05 | 38 | 178 | 5 | CID000004544 | |
| Drug | amoebal | 1.65e-05 | 41 | 178 | 5 | CID000001985 | |
| Drug | bromocolchicine | 1.95e-05 | 21 | 178 | 4 | CID000161518 | |
| Drug | colchifoline | 1.95e-05 | 21 | 178 | 4 | CID000100132 | |
| Drug | Ustiloxin A | 1.95e-05 | 21 | 178 | 4 | CID000164454 | |
| Drug | SRI-3072 | 1.95e-05 | 21 | 178 | 4 | CID000493469 | |
| Drug | Ceforanide [60925-61-3]; Down 200; 7.6uM; MCF7; HT_HG-U133A | 2.03e-05 | 191 | 178 | 9 | 5351_DN | |
| Drug | ABT-751 | 2.34e-05 | 44 | 178 | 5 | CID003035714 | |
| Drug | 3,4,5-trimethoxyacetophenone | 2.37e-05 | 22 | 178 | 4 | CID000014345 | |
| Drug | AC1L1GIQ | 2.37e-05 | 22 | 178 | 4 | CID000003700 | |
| Drug | 2,4-dichlorobenzyl thiocyanate | 2.37e-05 | 22 | 178 | 4 | CID000098538 | |
| Drug | SureCN13401588 | 2.37e-05 | 22 | 178 | 4 | CID009897422 | |
| Drug | N-methyldemecolcine | 2.37e-05 | 22 | 178 | 4 | CID000023759 | |
| Drug | NSC-339672 | 2.37e-05 | 22 | 178 | 4 | CID000433930 | |
| Drug | Pindolol [13523-86-9]; Down 200; 16.2uM; MCF7; HT_HG-U133A | 2.39e-05 | 195 | 178 | 9 | 6834_DN | |
| Drug | Ioversol [87771-40-2]; Up 200; 5uM; PC3; HT_HG-U133A | 2.59e-05 | 197 | 178 | 9 | 6726_UP | |
| Drug | Hydralazine hydrochloride [304-20-1]; Down 200; 20.4uM; PC3; HT_HG-U133A | 2.70e-05 | 198 | 178 | 9 | 4282_DN | |
| Drug | 3,4,5-trimethoxybenzaldehyde | 2.85e-05 | 23 | 178 | 4 | CID000006858 | |
| Drug | AC1L2P05 | 2.85e-05 | 23 | 178 | 4 | CID000125688 | |
| Drug | 2,3,4-tabp | 2.85e-05 | 23 | 178 | 4 | CID000125548 | |
| Drug | NSC-373301 | 2.85e-05 | 23 | 178 | 4 | CID000341375 | |
| Drug | NSC355636 | 2.85e-05 | 23 | 178 | 4 | CID000100176 | |
| Drug | IKP104 | 2.85e-05 | 23 | 178 | 4 | CID000130739 | |
| Drug | fluorescein-colchicine | 2.85e-05 | 23 | 178 | 4 | CID003035871 | |
| Drug | 3-demethylthiocolchicine | 2.85e-05 | 23 | 178 | 4 | CID000084076 | |
| Drug | 2,3,4-TCB | 2.85e-05 | 23 | 178 | 4 | CID000129239 | |
| Drug | N-acetylcolchinol | 2.85e-05 | 23 | 178 | 4 | CID000097865 | |
| Drug | Scopoletin [92-61-5]; Up 200; 20.8uM; HL60; HT_HG-U133A | 2.92e-05 | 200 | 178 | 9 | 3131_UP | |
| Drug | parbendazole | 3.40e-05 | 24 | 178 | 4 | CID000026596 | |
| Drug | tropolone methyl ether | 3.40e-05 | 24 | 178 | 4 | CID000016546 | |
| Drug | 7-epi-cephalomannine | 3.40e-05 | 24 | 178 | 4 | CID000330401 | |
| Drug | NABV | 3.40e-05 | 24 | 178 | 4 | CID000175959 | |
| Drug | AC1L4TG7 | 3.40e-05 | 24 | 178 | 4 | CID000163705 | |
| Drug | moscatilin | 3.40e-05 | 24 | 178 | 4 | CID000176096 | |
| Drug | NSC-36768 | 3.40e-05 | 24 | 178 | 4 | CID000165441 | |
| Drug | deacetamidocolchicine | 3.40e-05 | 24 | 178 | 4 | CID000014995 | |
| Drug | colchicide | 3.40e-05 | 24 | 178 | 4 | CID000120712 | |
| Drug | LEO275 | 3.64e-05 | 79 | 178 | 6 | CID000018140 | |
| Drug | mpMap | 4.02e-05 | 25 | 178 | 4 | CID000100806 | |
| Drug | AC1Q6P06 | 4.02e-05 | 25 | 178 | 4 | CID000160263 | |
| Drug | allocolchicine | 4.02e-05 | 25 | 178 | 4 | CID000196989 | |
| Drug | 1069C85 | 4.02e-05 | 25 | 178 | 4 | CID006918099 | |
| Drug | 55623-37-5 | 4.02e-05 | 25 | 178 | 4 | CID006438440 | |
| Drug | MDL 27048 | 4.02e-05 | 25 | 178 | 4 | CID006439188 | |
| Drug | NBD-colcemid | 4.02e-05 | 25 | 178 | 4 | CID000130594 | |
| Drug | 2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone | 4.02e-05 | 25 | 178 | 4 | CID000043264 | |
| Drug | CA1P | 4.02e-05 | 25 | 178 | 4 | CID006918545 | |
| Drug | peloruside A | 4.02e-05 | 25 | 178 | 4 | CID006918506 | |
| Drug | NSC142227 | 4.02e-05 | 25 | 178 | 4 | CID000073427 | |
| Drug | Z)-combretastatin A-4 | 4.40e-05 | 50 | 178 | 5 | CID000072686 | |
| Drug | NSC527981 | 4.72e-05 | 26 | 178 | 4 | CID000352796 | |
| Drug | NSC332029 | 4.72e-05 | 26 | 178 | 4 | CID000100073 | |
| Drug | indibulin | 4.72e-05 | 26 | 178 | 4 | CID000002929 | |
| Drug | pironetin | 4.72e-05 | 26 | 178 | 4 | CID006438891 | |
| Drug | isaxonine | 4.72e-05 | 26 | 178 | 4 | CID000071169 | |
| Drug | combretastatin | 4.85e-05 | 51 | 178 | 5 | CID000100154 | |
| Drug | TK-B | 4.85e-05 | 51 | 178 | 5 | CID000009074 | |
| Drug | magnesium sulfate | 5.33e-05 | 52 | 178 | 5 | CID000024083 | |
| Drug | AC1L1J4H | 5.51e-05 | 27 | 178 | 4 | CID000004862 | |
| Drug | dinitroanilines | 5.51e-05 | 27 | 178 | 4 | CID000136400 | |
| Drug | NSC292222 | 5.51e-05 | 27 | 178 | 4 | CID000099957 | |
| Drug | NSC D-669356 | 5.51e-05 | 27 | 178 | 4 | CID000178028 | |
| Drug | salicylate | NPL LIAS TUBA1C ABCC5 TUBA8 TUBA4A NOP9 TUBA1A NFX1 HSPA6 ABCC10 | 5.76e-05 | 328 | 178 | 11 | CID000000338 |
| Drug | NSC 370147 | 6.39e-05 | 28 | 178 | 4 | CID000182762 | |
| Drug | NSC72302 | 6.39e-05 | 28 | 178 | 4 | CID000118078 | |
| Drug | benomyl | 6.77e-05 | 128 | 178 | 7 | CID000028780 | |
| Drug | bp U | 7.36e-05 | 29 | 178 | 4 | CID000368697 | |
| Drug | oxibendazole | 7.36e-05 | 29 | 178 | 4 | CID000004622 | |
| Drug | Aids106696 | 7.36e-05 | 29 | 178 | 4 | CID006475933 | |
| Drug | ddGDP | 7.36e-05 | 29 | 178 | 4 | CID000134739 | |
| Drug | AC1NBBHE | 8.44e-05 | 30 | 178 | 4 | CID004490620 | |
| Drug | eleutherobin | 8.44e-05 | 30 | 178 | 4 | CID006918335 | |
| Drug | azatoxin | 8.44e-05 | 30 | 178 | 4 | CID000125383 | |
| Drug | NSC617668 | 8.44e-05 | 30 | 178 | 4 | CID000357989 | |
| Drug | citostal | 8.44e-05 | 30 | 178 | 4 | CID000018991 | |
| Drug | thiocolchicine | 8.44e-05 | 30 | 178 | 4 | CID000017648 | |
| Drug | 1xa5 | 9.11e-05 | 93 | 178 | 6 | CID000157684 | |
| Drug | NSC609395 | 9.64e-05 | 31 | 178 | 4 | CID005488798 | |
| Drug | amiprophosmethyl | 9.64e-05 | 31 | 178 | 4 | CID000100524 | |
| Drug | AC7700 | 9.64e-05 | 31 | 178 | 4 | CID006918404 | |
| Drug | 3,4-dimethylhexane-2,5-dione | 9.64e-05 | 31 | 178 | 4 | CID000032851 | |
| Drug | tropone | 9.64e-05 | 31 | 178 | 4 | CID000010881 | |
| Drug | AC1L3V8I | 9.64e-05 | 31 | 178 | 4 | CID000122777 | |
| Drug | NSC332598 | 9.64e-05 | 31 | 178 | 4 | CID000615942 | |
| Drug | N,N'-ethylenebis(iodoacetamide | 9.64e-05 | 31 | 178 | 4 | CID000023678 | |
| Drug | AC1L1G95 | 1.09e-04 | 32 | 178 | 4 | CID000003583 | |
| Drug | NSC153858 | 1.09e-04 | 32 | 178 | 4 | CID000547450 | |
| Drug | E2-3,4-Q | 1.09e-04 | 32 | 178 | 4 | CID000067402 | |
| Drug | 2-demethylcolchicine | 1.09e-04 | 32 | 178 | 4 | CID000023757 | |
| Drug | mebendazole | 1.24e-04 | 33 | 178 | 4 | CID000004030 | |
| Drug | CA4P | 1.24e-04 | 33 | 178 | 4 | CID000370232 | |
| Drug | taltobulin | 1.24e-04 | 33 | 178 | 4 | CID006918637 | |
| Disease | microlissencephaly (implicated_via_orthology) | 3.94e-10 | 8 | 176 | 5 | DOID:0112234 (implicated_via_orthology) | |
| Disease | lissencephaly 3 (implicated_via_orthology) | 3.94e-10 | 8 | 176 | 5 | DOID:0112232 (implicated_via_orthology) | |
| Disease | polymicrogyria (implicated_via_orthology) | 3.94e-10 | 8 | 176 | 5 | DOID:0080918 (implicated_via_orthology) | |
| Disease | lissencephaly (implicated_via_orthology) | 5.18e-07 | 27 | 176 | 5 | DOID:0050453 (implicated_via_orthology) | |
| Disease | Intellectual Disability | CUX2 TRIO CAMK2B BRSK2 CASP2 FASN AP1B1 TUBA1A DIAPH1 MED12L PCYT2 UMPS DLG4 | 3.16e-06 | 447 | 176 | 13 | C3714756 |
| Disease | Neurodevelopmental Disorders | 2.05e-05 | 93 | 176 | 6 | C1535926 | |
| Disease | serine/threonine-protein kinase BRSK2 measurement | 1.06e-04 | 3 | 176 | 2 | EFO_0803063 | |
| Disease | Bipolar Disorder | CUX2 DSCAM HMGXB4 GRID1 TUBA8 OTX2 MTHFD1 SCN2A DLG4 DNAH8 PRODH | 1.47e-04 | 477 | 176 | 11 | C0005586 |
| Disease | purine-pyrimidine metabolic disorder (is_implicated_in) | 2.11e-04 | 4 | 176 | 2 | DOID:653 (is_implicated_in) | |
| Disease | hip bone mineral density, fat body mass | 2.96e-04 | 22 | 176 | 3 | EFO_0005409, EFO_0007702 | |
| Disease | liposarcoma | 5.22e-04 | 6 | 176 | 2 | C0023827 | |
| Disease | Barrett's esophagus | 6.12e-04 | 28 | 176 | 3 | EFO_0000280 | |
| Disease | Acute Coronary Syndrome | 9.98e-04 | 33 | 176 | 3 | C0948089 | |
| Disease | Generalized Epilepsy with Febrile Seizures Plus | 1.24e-03 | 9 | 176 | 2 | C3502809 | |
| Disease | Duchenne muscular dystrophy (implicated_via_orthology) | 1.29e-03 | 36 | 176 | 3 | DOID:11723 (implicated_via_orthology) | |
| Disease | Nonsyndromic Deafness | 1.42e-03 | 81 | 176 | 4 | C3711374 | |
| Disease | volumetric bone mineral density | 2.02e-03 | 42 | 176 | 3 | EFO_0007620 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 2.23e-03 | 152 | 176 | 5 | DOID:0060041 (implicated_via_orthology) | |
| Disease | hearing impairment | 2.86e-03 | 98 | 176 | 4 | C1384666 | |
| Disease | triacylglycerol 48:4 measurement | 3.07e-03 | 14 | 176 | 2 | EFO_0010407 | |
| Disease | peak expiratory flow | 3.14e-03 | 498 | 176 | 9 | EFO_0009718 | |
| Disease | Colorectal Carcinoma | ABCC5 LAMB3 GRID1 CDC14A KCNH4 PPP2R1B ABCG1 UMPS DSEL KDF1 DNAH8 | 3.40e-03 | 702 | 176 | 11 | C0009402 |
| Disease | arm span | 3.53e-03 | 15 | 176 | 2 | EFO_0005108 | |
| Disease | Alobar Holoprosencephaly | 3.53e-03 | 15 | 176 | 2 | C0431363 | |
| Disease | Lobar Holoprosencephaly | 4.02e-03 | 16 | 176 | 2 | C0431362 | |
| Disease | Semilobar Holoprosencephaly | 4.02e-03 | 16 | 176 | 2 | C0751617 | |
| Disease | Abnormal behavior | 4.02e-03 | 16 | 176 | 2 | C0233514 | |
| Disease | urate measurement, bone density | DSCAM WDR7 HMGXB4 ADGRB3 GRID1 DIAPH1 CABIN1 DNAH8 TEX44 EPHB1 | 4.18e-03 | 619 | 176 | 10 | EFO_0003923, EFO_0004531 |
| Disease | urinary albumin to creatinine ratio | 4.48e-03 | 179 | 176 | 5 | EFO_0007778 | |
| Disease | MAJOR AFFECTIVE DISORDER 2 | 4.54e-03 | 17 | 176 | 2 | C1839839 | |
| Disease | Holoprosencephaly | 4.54e-03 | 17 | 176 | 2 | C0079541 | |
| Disease | autosomal dominant intellectual developmental disorder (is_implicated_in) | 4.54e-03 | 17 | 176 | 2 | DOID:0060307 (is_implicated_in) | |
| Disease | platelet crit | RETREG2 BCAS3 ABCC5 ZNF407 ADGRV1 ACVRL1 PNKD FAM13B TLN1 PAK2 UMPS ZNF76 ABCC10 | 4.82e-03 | 952 | 176 | 13 | EFO_0007985 |
| Disease | Drug habituation | 5.06e-03 | 115 | 176 | 4 | C0013170 | |
| Disease | Drug abuse | 5.06e-03 | 115 | 176 | 4 | C0013146 | |
| Disease | Prescription Drug Abuse | 5.06e-03 | 115 | 176 | 4 | C4316881 | |
| Disease | Substance-Related Disorders | 5.06e-03 | 115 | 176 | 4 | C0236969 | |
| Disease | Drug Use Disorders | 5.06e-03 | 115 | 176 | 4 | C0013222 | |
| Disease | Drug Dependence | 5.06e-03 | 115 | 176 | 4 | C1510472 | |
| Disease | Substance Dependence | 5.06e-03 | 115 | 176 | 4 | C0038580 | |
| Disease | Substance Use Disorders | 5.06e-03 | 115 | 176 | 4 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 5.06e-03 | 115 | 176 | 4 | C0029231 | |
| Disease | kidney volume | 5.08e-03 | 18 | 176 | 2 | EFO_0600044 | |
| Disease | Substance abuse problem | 5.22e-03 | 116 | 176 | 4 | C0740858 | |
| Disease | neuroblastoma | 5.22e-03 | 116 | 176 | 4 | EFO_0000621 | |
| Disease | spine bone mineral density | 5.71e-03 | 119 | 176 | 4 | EFO_0007701 | |
| Disease | blood urea nitrogen measurement | 5.95e-03 | 452 | 176 | 8 | EFO_0004741 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SLEGLMELNGSSSQL | 1056 | Q9BXT4 | |
| IMGLSTILGKENTIE | 361 | P30154 | |
| IVGGIDSMSQSLALA | 126 | Q9H0S4 | |
| GSTEAAITLLTMGDL | 1981 | A6H8Y1 | |
| AMNSLTSLGTLQGLA | 331 | O95319 | |
| VLIGSGLSSEQQKML | 571 | Q99728 | |
| GTMTSLVAQSLGLLI | 541 | P45844 | |
| AGDGMSQVTKTLLDL | 591 | O60242 | |
| SINKILSGLDDMSIG | 351 | Q9UNH5 | |
| LGEMDLLTQSLGVDT | 16 | Q7Z5R6 | |
| SLLTLMDGIGSEVSE | 476 | Q8NB90 | |
| NSTMILSLVLERTGG | 4531 | Q8WXG9 | |
| SLILKASEQGDSMLG | 161 | P37023 | |
| LATSSVQMGAVDLLG | 646 | Q10567 | |
| REMISLLDSNGTGTL | 581 | A6NHC0 | |
| SGQLDGLELLSMLTA | 86 | Q99674 | |
| TGVMDSLLEALQSGA | 1196 | O60610 | |
| EKVLGLSQGSVSDML | 921 | O14529 | |
| TSGMLLVTTDTLGHD | 361 | Q9H6U6 | |
| IIDASGESGLTQLLM | 106 | Q9H257 | |
| GQRTTLTGLDVQDML | 191 | P23280 | |
| LADEMGLGKTIQSIT | 991 | Q9P2D1 | |
| LQDSLSDGTLIAMGL | 976 | Q96F81 | |
| LILATEATSSLLGGM | 1901 | Q2TAZ0 | |
| ASVSVLGDILGSAMQ | 946 | P01023 | |
| LSVGISTELDMAVSG | 2496 | Q6ZS30 | |
| SMHILEGDQGVISSL | 736 | Q8NDT2 | |
| ESMIQLAEGLITGTV | 641 | P29074 | |
| LLGTTVTFDDLMGIL | 401 | Q96JP0 | |
| MTSEDLLRIGITLAG | 946 | P54762 | |
| LSEVITSMGGLDGEL | 1361 | Q5T3U5 | |
| STNRTGSEMLQELLG | 101 | Q86U38 | |
| MELRNSTLGSGFILV | 1 | A6NM03 | |
| RLTGLSEMDLISTIG | 301 | Q12891 | |
| ALSLAISGMDILGIT | 206 | Q6IF63 | |
| MLGVLINGTLASDLS | 1571 | Q86YW9 | |
| LGKQLAETLETAMGT | 1276 | Q9BY89 | |
| DTGIRLLETQLMISG | 1581 | Q03001 | |
| TGELLTMTQVARGLD | 4486 | Q8NDA2 | |
| SVELGFTGLTDDMVL | 206 | Q8NAA5 | |
| QLLGTSEEDSMVGTL | 146 | Q9HB07 | |
| LMNLLANDDLTTTGT | 311 | Q14117 | |
| DGVNLSSELGDMLKT | 791 | Q9NYF5 | |
| MVVGTGTSLALSSLL | 1 | Q8N6L1 | |
| ITLFGTQDDTGMTLL | 991 | Q8IVV2 | |
| GMASLQVGDSLLETS | 161 | Q8IWQ3 | |
| KGTGELTQLLNSMLT | 26 | O00757 | |
| TQGVSTTDLVGRMLL | 141 | Q99447 | |
| QQVELLGMILGTETS | 71 | A0PG75 | |
| LGIIMISDSGLLSLS | 196 | Q8NGD5 | |
| LLGGDVTLAISMTFL | 276 | P09131 | |
| GADIILDMATLTGAQ | 361 | Q8NDH3 | |
| GTESGEIITLMEDSL | 1441 | Q96JB1 | |
| LLMGSCDLATTLTGT | 181 | Q8NG66 | |
| TDMQLGGSVEISKLI | 921 | Q12986 | |
| SGQSLLMLGSSDVII | 511 | Q9P1Y6 | |
| SVGTMETGTALLDLR | 961 | Q9UQ05 | |
| DVISKTSIMLGLGEN | 271 | O43766 | |
| NLAMTGEVSLTGKIL | 876 | P36776 | |
| ELLQMLVTGGVSSQL | 921 | A8MYU2 | |
| NLMGTSEEGNLLSTV | 6 | Q58A44 | |
| RLQETEGMVAVSGSL | 541 | Q9UGU5 | |
| EGMVAVSGSLSVLLD | 546 | Q9UGU5 | |
| MGDNITSITEFLLLG | 1 | Q96R45 | |
| VLTMAGNLGIITLTS | 36 | Q8NGG0 | |
| GLTGSQFLSVENMIL | 441 | Q9C091 | |
| SLLSSLQDNGLTDVM | 571 | Q7Z6Z7 | |
| LINARLTSEVTGMGT | 356 | P57721 | |
| QGMSLLVRSDSDGSV | 36 | Q6ZMV5 | |
| LLFVLLGMSQAGSET | 16 | Q9Y5F2 | |
| GSQLDSMLGSLQSDL | 331 | P49023 | |
| SAILGQMTLLEGSIA | 606 | O15440 | |
| SDNVLLGMEGSVKLT | 371 | Q13177 | |
| SLGQTSMSAQALLEG | 146 | O95400 | |
| DVSMDSGSLVLSAIG | 321 | P81408 | |
| NLGGELIMSALDSVT | 791 | Q9UI47 | |
| MRSIQETLGESGSLL | 86 | Q96BP2 | |
| MSLGLAGAQEVELTL | 1 | Q5TZA2 | |
| EGLALINGTQMITSL | 301 | P42357 | |
| GQATLERLEGMLSQS | 181 | P54105 | |
| LMGIEQALSADSSGS | 791 | Q9Y6J0 | |
| TGMAGALSALDNTIE | 21 | Q6ZS62 | |
| ALVLDIGTGTGLLSM | 66 | Q9NVM4 | |
| SGILEILLVESGAMT | 506 | Q13698 | |
| GALMSAILESLQTAG | 221 | Q7L775 | |
| MILLNTGLEGTVAEN | 366 | Q8WW52 | |
| NELGSGIMELTDTEL | 31 | Q8WU20 | |
| VELGSGVMELTQSEL | 31 | O43559 | |
| TGSDLMVLLLLGDES | 291 | P52306 | |
| MGTVSGQLSLQDALL | 121 | Q9NUB4 | |
| RIIGATDSSGELMFL | 121 | P83916 | |
| KMDTGVVLLSGNDTL | 191 | Q3MJ40 | |
| DGSLERILIGELMTS | 1036 | Q6ZUT9 | |
| SLSISSGILTLVGMG | 181 | O14791 | |
| GMASLQVGDSLLETS | 176 | Q8TDC3 | |
| DLREQLMNSSLGSGT | 406 | P78352 | |
| GTITSSDPGLEILNM | 96 | Q12912 | |
| GIQDVLVGSSMETLI | 106 | Q8NFN8 | |
| DLMTQGILALVTSTG | 81 | Q9ULK0 | |
| GSQAIMLRSADLTGL | 1136 | Q13751 | |
| TTGDLLVGRNTQLMA | 31 | A4D0S4 | |
| GRLSMTGSTEDTILE | 336 | Q8IYT3 | |
| SVLLTVGGADTALMI | 1251 | Q6ZMW3 | |
| LSLGLETAGGVMTTL | 401 | P17066 | |
| MARTLTGLINVGSID | 601 | Q8IXB1 | |
| TSGGKTLVAEILMLQ | 361 | Q8TDG4 | |
| KMDTGVVLLSGNDTL | 191 | A2RUR9 | |
| DSSLADLGLDSLMSV | 2146 | P49327 | |
| EKGIQGLIVMSTSLE | 4211 | Q9P225 | |
| LQATTMSGKIGALEI | 306 | P46059 | |
| ATNMIALLTGALVTG | 226 | Q8IZU8 | |
| DGLGSIAIDTTQLNM | 26 | Q8TC92 | |
| SAEDLGVSGALTVLM | 601 | P11586 | |
| QGHLEDMLLTTLSGL | 111 | P42575 | |
| VLTLLSDTEMTSIGG | 1146 | P46019 | |
| AVNGLSLTTSGMDLL | 11 | P32243 | |
| AMLAGTDLGLSTATI | 66 | Q8NH55 | |
| GLTTNEGLKMLVTIS | 1586 | O60469 | |
| GMSLVIDTQLLNGAD | 1206 | P0C091 | |
| DEQLLSALVMGATGA | 201 | Q9BXD5 | |
| SGTTMGLVEQAKSLL | 331 | Q13554 | |
| SFIMGSDDVLLSVLG | 426 | Q13033 | |
| GNSDMLVVTTKAGLL | 136 | Q86VP1 | |
| TAQTAVLMETLGALG | 236 | Q96HN2 | |
| GNAETMLSSLDTVLG | 266 | Q8N490 | |
| MLSSLDTVLGLGDDT | 271 | Q8N490 | |
| IGSFLMGLLSVVDLS | 311 | Q86VL8 | |
| GLLGNLLTSLMGSSE | 296 | Q7L5D6 | |
| LLTSLMGSSEQEDGE | 301 | Q7L5D6 | |
| SEEIMGLTILAAGTS | 531 | Q9UI40 | |
| IDMLLTSGSAEGSLQ | 281 | Q96NG3 | |
| NLSQGMEFELLGLTT | 56 | Q8NGC0 | |
| ESRISDTGSAGLMLV | 36 | P30101 | |
| AVILLEGTMNLTGET | 246 | O75448 | |
| LGLSLGMSEATSEAE | 26 | Q8NC44 | |
| FTAETLGVSGTMDLL | 301 | O43272 | |
| VSTLLGVLMLAGSEF | 1131 | Q13635 | |
| MTGEDSISTLGLILG | 1 | A0A1B0GVV1 | |
| ETMVGSGLSQDELTV | 336 | Q8NAX2 | |
| LADEMGLGKTIQTIS | 641 | Q6ZRS2 | |
| SSNAGLSLSQLLDEM | 161 | Q96AP0 | |
| DGSGRLDQLLSLSMV | 56 | Q96HQ2 | |
| ELLTGMAEIFGTELT | 36 | Q92989 | |
| SVLEGLGSRTQLAML | 751 | Q8IZ52 | |
| LDNLIGSGLMAVASS | 261 | Q6P4Q7 | |
| MTSLLDRGEGSISSL | 276 | Q53QW1 | |
| TGLPLELIDGSTLSM | 656 | Q8TCY9 | |
| GLVALSSDNTASLMG | 396 | Q8WWU5 | |
| MCTSGQIIGSLLVLS | 1 | Q5HYL7 | |
| LDSGIGSLESQMSEL | 436 | Q5D1E8 | |
| LQDLAGTLGSMLAVT | 261 | Q03395 | |
| RTSVGSLQGLAVDMD | 211 | Q7RTY8 | |
| TGLLTLGVKESAMVN | 176 | P30825 | |
| ISAKTMLESAGGLIQ | 1601 | Q9Y490 | |
| DVMLENLTLTTSLGG | 41 | Q9Y2P7 | |
| GSQGLLEEMLAASSS | 1451 | Q9C0C2 | |
| VSLSLMELGLANVEG | 831 | Q99250 | |
| GLLTLNTVCLMSGIS | 96 | Q96B77 | |
| IGDTRLSTMETGTGL | 296 | P29144 | |
| LLIAEMSSTGSLATG | 366 | P11172 | |
| LISDLSNMEGKTGNT | 126 | O43847 | |
| LEGSMRTLVGLLTSN | 106 | Q96DC7 | |
| QDMSISLAALELLSG | 776 | Q86X10 | |
| LVSEIQLMAATGGTE | 36 | Q9NV29 | |
| AGLMLVTGSINTLSA | 11 | Q8N357 | |
| ITGQAMEIGSAALTI | 1311 | A7E2V4 | |
| IGMTQEELVSNLGTI | 161 | Q12931 | |
| KLGVEMLSESQLSDG | 271 | Q8N0Z9 | |
| SVTLTLADTQGMLSG | 1566 | Q9UL36 | |
| GSGFTSLLMERLSVD | 146 | Q71U36 | |
| ENMGLLTSGVEFESL | 616 | Q96Q05 | |
| GLVMNSDILGATTEV | 546 | Q96JP5 | |
| LEKGMLASEELSQSG | 811 | Q9C0G0 | |
| GSGFTSLLMERLSVD | 146 | P68363 | |
| SINGDLMELNSIGVI | 361 | Q5H9R7 | |
| GSEEGLAMTTSISLQ | 366 | Q9Y4E6 | |
| GDSEMVALLTALSQG | 221 | O95125 | |
| GSGFTSLLMERLSVD | 146 | Q9BQE3 | |
| VALLEQLGTTLDMGE | 176 | Q9H898 | |
| MESLGLHTVTLSDGT | 1 | P36508 | |
| GSGFTSLLMERLSLD | 146 | Q9NY65 | |
| GSGFTSLLMERLSVD | 146 | P68366 | |
| GESMLNAGLITASSL | 926 | O75962 | |
| LISSMLDQVDGSFGI | 1026 | Q9H0D2 | |
| MGSSLLSGRLDQLLS | 291 | Q15048 | |
| LMTSGLGDSLLAETE | 301 | Q5JTD7 | |
| LGSSNLGSSEMLLSE | 941 | Q86UW6 |